Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1967
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1985 1
1987 2
1989 1
1991 1
1994 2
1996 2
1997 2
1999 3
2000 1
2001 1
2002 2
2003 6
2004 6
2005 5
2006 10
2007 5
2008 9
2009 3
2010 4
2011 2
2012 5
2013 6
2014 3
2015 5
2016 9
2017 6
2018 6
2019 7
2020 7
2021 5
2022 9
2023 9
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis.
Chitsuthipakorn W, Hoang MP, Kanjanawasee D, Seresirikachorn K, Snidvongs K. Chitsuthipakorn W, et al. Curr Allergy Asthma Rep. 2023 Dec;23(12):689-701. doi: 10.1007/s11882-023-01116-8. Epub 2023 Nov 23. Curr Allergy Asthma Rep. 2023. PMID: 37995018 Review.
PURPOSE OF REVIEW: To analyze and compare the effects of epistaxis treatments for Hereditary Hemorrhagic Telangiectasia (HHT) patients. RECENT FINDINGS: Of total of 21 randomized controlled trials (RCT), the data from 15 RCTs (697 patients, 7 treatments: timolol, pr …
PURPOSE OF REVIEW: To analyze and compare the effects of epistaxis treatments for Hereditary Hemorrhagic Telangiectasia (HHT) …
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Al-Samkari H. Al-Samkari H. Blood. 2021 Feb 18;137(7):888-895. doi: 10.1182/blood.2020008739. Blood. 2021. PMID: 33171488 Free article. Review.
Hereditary hemorrhagic telangiectasia (HHT) management is evolving because of the emergence and development of antiangiogenic therapies to eliminate bleeding telangiectasias and achieve hemostasis. ...
Hereditary hemorrhagic telangiectasia (HHT) management is evolving because of the emergence and development of antiangiogenic therapi
Hereditary haemorrhagic telangiectasia.
Rimmer J, Lund VJ. Rimmer J, et al. Rhinology. 2015 Sep;53(3):195-203. doi: 10.4193/Rhino14.274. Rhinology. 2015. PMID: 26460394 Review.
BACKGROUND: Hereditary haemorrhagic telangiectasia is an autosomal dominant vascular disease characterized by recurrent epistaxis, mucocutaneous telangiectasia and visceral arteriovenous malformations. ...Epistaxis is often the major symptom, significantly af …
BACKGROUND: Hereditary haemorrhagic telangiectasia is an autosomal dominant vascular disease characterized by recurrent epistaxis
Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review.
Zhang E, Virk ZM, Rodriguez-Lopez J, Al-Samkari H. Zhang E, et al. Thromb Res. 2023 Jun;226:150-155. doi: 10.1016/j.thromres.2023.04.017. Epub 2023 May 3. Thromb Res. 2023. PMID: 37163869 Free PMC article. Review.
INTRODUCTION: Data describing safety and tolerability of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia (HHT), the second-most-common inherited bleeding disorder, is limited. ...Complications of therapy included worsened HHT-associated bl …
INTRODUCTION: Data describing safety and tolerability of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiec …
Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature.
Dupuis O, Delagrange L, Dupuis-Girod S. Dupuis O, et al. Orphanet J Rare Dis. 2020 Jan 7;15(1):5. doi: 10.1186/s13023-019-1286-z. Orphanet J Rare Dis. 2020. PMID: 31910869 Free PMC article. Review.
BACKGROUND: Hereditary haemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular disorder that has prevalence of 1:5000 to 1:8000, and which is characterised by recurrent epistaxis, cutaneous telangiectasia, and arteriovenous malformations (AVMs) …
BACKGROUND: Hereditary haemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular disorder that has prevalence of 1 …
Hereditary hemorrhagic telangiectasia.
Chung MG. Chung MG. Handb Clin Neurol. 2015;132:185-97. doi: 10.1016/B978-0-444-62702-5.00013-5. Handb Clin Neurol. 2015. PMID: 26564080 Review.
Hereditary hemorrhagic telangiectasia (HHT) also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that is characterized by multiple arteriovenous malformations (AVMs) involving the skin, mucosal surfaces, and internal organs. HHT has an age-dependent
Hereditary hemorrhagic telangiectasia (HHT) also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that is chara
Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B, Abdel-Aty Y, Marks L, Lal D, Marino M. Thiele B, et al. Ann Otol Rhinol Laryngol. 2023 Jan;132(1):82-90. doi: 10.1177/00034894221078075. Epub 2022 Feb 12. Ann Otol Rhinol Laryngol. 2023. PMID: 35152768 Review.
OBJECTIVES: Hereditary hemorrhagic telangiectasia (HHT) is a common inherited condition characterized by mucosal telangiectasias, recurrent epistaxis, and arteriovenous malformations. ...Reported variables included number of injections, months of follow up, changes …
OBJECTIVES: Hereditary hemorrhagic telangiectasia (HHT) is a common inherited condition characterized by mucosal telangiectasias, rec …
[Osler's disease].
Ahlhelm F, Lieb J, Schneider G, Müller U, Ulmer S. Ahlhelm F, et al. Radiologe. 2013 Dec;53(12):1084-90. doi: 10.1007/s00117-013-2552-z. Radiologe. 2013. PMID: 24276214 Review. German.
Osler's disease, also known as hereditary hemorrhagic telangiectasia (HHT) and Osler-Weber-Rendu syndrome, is an autosomal dominant disorder leading to abnormal blood vessel formation in the skin, mucous membranes and often in organs, such as the lungs, liver and brain (ar …
Osler's disease, also known as hereditary hemorrhagic telangiectasia (HHT) and Osler-Weber-Rendu syndrome, is an autosomal dominant d …
Update on pulmonary arteriovenous malformations.
Salibe-Filho W, Oliveira FR, Terra-Filho M. Salibe-Filho W, et al. J Bras Pneumol. 2023 May 1;49(2):e20220359. doi: 10.36416/1806-3756/e20220359. eCollection 2023. J Bras Pneumol. 2023. PMID: 37132738 Free PMC article. Review.
The primary etiology of pulmonary arteriovenous malformations is hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, with mutations in the ENG gene on chromosome 9 (HHT type 1) or in the ACVRL1/ALK1 complex (HHT type 2). Epistaxis
The primary etiology of pulmonary arteriovenous malformations is hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osl …
[Hereditary hemorrhagic telangiectasia].
Duffau P, Lazarro E, Viallard JF. Duffau P, et al. Rev Med Interne. 2014 Jan;35(1):21-7. doi: 10.1016/j.revmed.2013.02.022. Epub 2013 Mar 19. Rev Med Interne. 2014. PMID: 23517771 Review. French.
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) is a development disorder of the vasculature characterized by telangiectases and arteriovenous malformations in specific locations. ...Mutations in at least five genes may result in hereditary hemorr
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) is a development disorder of the vasculature characterized by tela
140 results